Patients Stopping Anti-Obesity Medications Regain Weight Four Times Faster Compared to Those on Conventional Diets
New research suggests that people who discontinue new weight-loss injections like semaglutide or tirzepatide may regain shed pounds far faster than those who halt traditional lifestyle regimens.
Findings released in a leading medical journal points out that while overweight people frequently drop about a fifth of their total mass while using the jabs, the mass returns at an estimated rate of nearly a kilo each month once they quit.
"Individuals using such medications must be cognizant of the risk of fast rebound weight gain when the medication concludes," cautioned researcher Dr. Susan Jebb.
That rate of regain means a return to pre-treatment weight in about 18 months.
Comparing Treatments
The study, which looked at 37 of studies involving thousands of participants, contrasted the effects of the injectable medications with older methods.
Scientists point out that people who shed pounds through dieting usually have a less rapid weight regain—around 0.1 kg a month—post-intervention.
The Reason for the Fast Regain
Experts suggest the mechanism of the injections is key to understanding the amplified regain.
These medications copy a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication means hunger is no longer kept in check, making excessive eating far more likely."
An Ongoing Condition?
Medical guidelines suggest the jabs for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.
Professionals contend that, given the likelihood of weight regain, the treatment might need to be long-term.
This perspective is echoed by drug manufacturers, who say that the results "highlight the persistent nature of obesity," comparing it to managing diseases like diabetes.
User Accounts
Users who have come off the jabs describe a sudden resurgence of appetite.
"I experienced a switch flipping and you become starving," described one woman.
This difficulty is compounded if individuals have not developed sustainable lifestyle or habit modifications during treatment.
Growing Use
Recent estimates suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial.
- Use is greater among women than males.
- The middle-aged demographic shows the highest level of interest.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, experts stress that while these medications are potent tools for shedding pounds, they are not a magic cure and lasting health benefits relies on integrated lifestyle management.